For everyone interested in investing in memory

=== SUMMARY === - The post compares SK Hynix (via GDR HY9H) to Micron, arguing Hynix is deeply undervalued based on DCF (68% undervalued), low P/E (13.5x), forward P/E (4.6x), and PEG (0.4x). - Author suggests the valuation gap persists partly because US investors cannot easily buy Hynix, but European investors can use the German-listed GDR (HY9H). - Quality assessment: Moderately well-researched DD – uses specific valuation multiples and a DCF claim, but lacks detailed cash flow derivation and includes no risk analysis beyond accessibility. === SENTIMENT === BULLISH === TRADE IDEAS === HY9H - LONG | confidence: 0.80 | sentiment: +0.70 Speaker: u/springmeds Thesis: 1. THE FACT: Author states SK Hynix has DCF showing 68% undervaluation vs. Micron’s 138% overvaluation, with P/E 13.5x (vs. 29.9x), forward P/E 4.6x (vs. 8.2x), and PEG 0.4x (vs. 1.1x). 2. THE BRIDGE: The wide valuation discount relative to Micron creates a mean-reversion opportunity; limited US access may keep the mispricing persistent but provides a favorable entry for eligible investors. 3. THE VERDICT: SK Hynix appears deeply undervalued on traditional value metrics while its competitor trades at a significant premium, making the GDR a potential long-term value play. 4. RISKS: KOR/ Germany exchange liquidity, currency risk, semiconductor cyclicality, DRAM price downturn, limited US investor access reducing price discovery. Timeframe: medium-term Key Points: - DCF implies 68% undervaluation vs Micron. - P/E: 13.5x; Forward P/E: 4.6x. - PEG ratio of 0.4x suggests growth-adjusted cheapness. - GDR (HY9H) accessible to European investors. - US investors may lack direct access to this trade. No additional actionable trade ideas explicitly stated (short Micron is implied but not recommended).